Volatile Biomarkers for Early Detection and Characterisation of Gastric and Colorectal Neoplasms
Funding source: EuroNanoMed II
Grant agreement number: EURONANOMED2- 01/2014
Date: January 2014 – July 2017
Description: The project aims to develop and validate innovative, non-invasive, user-friendly, and cost-effective tools for the screening and early detection of gastric cancer (GC), colorectal cancer (CRC), and related premalignant conditions, supporting more personalized patient care. Bringing together leading expert centers in nanotechnology-based breath analysis and specialists in clinical medicine, laboratory diagnostics, and epidemiology, the project is designed to address cancer detection in high-risk regions.
We use cookies to improve your experience on our site. By using our site, you consent to cookies. You can read our Privacy Policy.
This website uses cookies
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.
Name
Description
Duration
Service URL
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.